Adam S. Grossman
2020
In 2020, Adam S. Grossman earned a total compensation of $2M as Director, President and Chief Executive Officer at ADMA Biologics, a 15% increase compared to previous year.
Compensation breakdown
Bonus | $486,000 |
---|---|
Option Awards | $544,517 |
Salary | $600,000 |
Stock Awards | $291,500 |
Other | $40,124 |
Total | $1,962,141 |
Grossman received $600K in salary, accounting for 31% of the total pay in 2020.
Grossman also received $486K in bonus, $544.5K in option awards, $291.5K in stock awards and $40.1K in other compensation.
Rankings
In 2020, Adam S. Grossman's compensation ranked 5,604th out of 13,090 executives tracked by ExecPay. In other words, Grossman earned more than 57.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,604 out of 13,090 | 57th |
Division Manufacturing | 2,313 out of 5,624 | 59th |
Major group Chemicals And Allied Products | 923 out of 2,257 | 59th |
Industry group Drugs | 798 out of 1,957 | 59th |
Industry Biological Products, Except Diagnostic Substances | 194 out of 411 | 53rd |
Source: SEC filing on April 7, 2021.
Grossman's colleagues
We found two more compensation records of executives who worked with Adam S. Grossman at ADMA Biologics in 2020.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019